# Amazon Health **Amazon Health** is [[Amazon]]'s push into care delivery and pharmacy — the most aggressive **Big Tech** entry into the [[Healthcare Industry Ecosystem]]. It is the tech-platform version of the [[Vertical Integration]] strategy that [[UnitedHealth Group]] and [[CVS Health]] built by acquisition: own the primary-care visit, the prescription, the fulfillment logistics, and the data layer underneath. ## The Three Pillars Amazon's stated strategy rests on three integrated pieces: - **One Medical** — membership-based primary and virtual care. Amazon acquired it in 2023 for roughly **$3.9 billion**, its largest healthcare bet, and now bundles discounted One Medical virtual care into Amazon Prime. - **Amazon Pharmacy** — online and same-day prescription fulfillment, built on **PillPack** (acquired 2018 for about $750 million). Amazon is expanding same-day delivery toward ~4,500 U.S. cities by end of 2026 and is placing prescription **kiosks inside One Medical clinics**. Its **RxPass** program offers a flat $5/month generic subscription for Prime members. - **AWS** — the cloud-and-data backbone that ties the clinical and fulfillment sides together and powers Amazon's ambitions in analytics and value-based care. ## The GLP-1 and Value-Based Care Play Amazon One Medical launched a **GLP-1 weight-management program** integrating primary care, virtual visits, and Amazon Pharmacy fulfillment — including same-day delivery of drugs like Ozempic — placing Amazon directly inside the decade's defining [[Drug Pricing]] story (see [[GLP-1 Drugs]]). The longer-term aim is **value-based care**: assuming financial risk for populations, particularly in [[Medicare Advantage]] and large-employer groups — the same risk-bearing model that drives the incumbent [[Managed Care]] conglomerates. ## Why It Matters Here Amazon Health is the test of whether **Big Tech** disrupts the health-industry incumbents or simply joins them. The disruptor case: lower prices, price transparency, and convenience (RxPass, $5 generics, same-day delivery) aimed squarely at the opacity documented across the [[Drug Pricing]] cluster. The concentration case: a single platform combining health data, an [[Amazon]] retail relationship, AWS infrastructure, primary care, and pharmacy raises exactly the data-privacy and market-power concerns that [[Big Tech]] critics flag — now applied to the most sensitive category of personal data. Its earlier, failed attempt — **Haven**, the 2018–2021 joint venture with JPMorgan and Berkshire Hathaway — is the cautionary precedent for how hard this market is to crack. See [[Healthcare Industry Ecosystem]] and [[Vertical Integration]].